Search Results - "Lester-Coll NH"

The training paradox in oncosexuality: a multinational survey on clinician attitudes, barriers, and sexual health communication in geriatric prostate cancer care.

Authors: Loganadane G Motta M Lester-Coll NH et al.

Source: World journal of urology [World J Urol] 2026 Jul 16; Vol. 44 (1). Date of Electronic Publication: 2026 Jul 16.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Springer International Country of Publication: Germany NLM ID: 8307716 Publication Model: Electronic Cited Medium: Internet ISSN: 1433-8726 (Electronic) Linking ISSN: 07244983 NLM ISO Abbreviation: World J Urol Subsets: MEDLINE

Author Reply.

Authors: Lester-Coll NH Park HS Gross CP et al.

Source: Urology [Urology] 2016 Oct; Vol. 96, pp. 134-135. Date of Electronic Publication: 2016 Aug 01.

Publication Type: Letter; Comment

Journal Info: Publisher: Elsevier Science Country of Publication: United States NLM ID: 0366151 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-9995 (Electronic) Linking ISSN: 00904295 NLM ISO Abbreviation: Urology Subsets: PubMed not MEDLINE

Permanent seed brachytherapy for prostate cancer: Monotherapy, combined, and salvage approaches remain effective and well-tolerated options.

Authors: Esteves, Sérgio C. B. Moschini, Vinicius T. Martins, Jumara et al.

Source: Journal of Contemporary Brachytherapy. 2026, Vol. 18 Issue 1, p23-31. 9p.

Low-dose radiotherapy combined with chemoimmunotherapy yields superior survival outcomes compared with chemoimmunotherapy alone for patients with small cell lung cancer with liver metastasis: a retrospective study.

Authors: Zhang, Yu Li, Wenpeng Zhang, Wenwen et al.

Source: BMC Cancer. 11/19/2025, Vol. 25 Issue 1, p1-10. 10p.

Survival Outcomes in Lung Cancer Patients Newly Diagnosed Through Brain Metastasis Surgery: Impact of Druggable Mutations and Radiotherapy.

Authors: Chuang, Tzu- Hsu, Kuo-Hsuan Lee, Po-Hsin et al.

Source: OncoTargets & Therapy. Jun2025, Vol. 18, p751-761. 11p.

Advances, limitations and perspectives in the use of celecoxib-loaded nanocarriers in therapeutics of cancer.

Authors: Oliveira Santos, Miguel de Jesus Teles-Souza, Jéssica de Araújo-Calumby, Renata Freitas et al.

Source: Discover Nano; 9/6/2024, Vol. 19 Issue 1, p1-18, 18p

Advancing medulloblastoma therapy: strategies and survival insights.

Authors: Pan Z Bao J Wei S

Source: Clinical and experimental medicine [Clin Exp Med] 2025 Apr 16; Vol. 25 (1), pp. 119. Date of Electronic Publication: 2025 Apr 16.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 100973405 Publication Model: Electronic Cited Medium: Internet ISSN: 1591-9528 (Electronic) Linking ISSN: 15918890 NLM ISO Abbreviation: Clin Exp Med Subsets: MEDLINE

Managing vestibular schwannomas with radiosurgery and radiotherapy: AGREE II appraisal of clinical practice guidelines.

Authors: Lakshmipathy, Deepak Winter, Eric Fritz, Christian et al.

Source: Journal of Medical Imaging & Radiation Oncology. Jun2024, Vol. 68 Issue 4, p462-471. 10p.

Brain metastases in Japanese NSCLC patients: prognostic assessment and the use of osimertinib and immune checkpoint inhibitors—retrospective study.

Authors: Higaki, Hajime Nishioka, Kentaro Otsuka, Manami et al.

Source: Radiation Oncology. 2/7/2023, Vol. 18 Issue 1, p1-6. 6p.

Comprehensive high-throughput sequencing analysis and verification of miRNAs isolated from bronchial epithelial cells undergoing radiation-induced epithelial-mesenchymal transition.

Authors: Hou, Yifan Zhou, Shenghui Wang, Ping et al.

Source: Science Progress. Jul-Sep2025, Vol. 108 Issue 3, p1-26. 26p.

The impact of anthropometric measurements on radiotherapy planning for patients with breast cancer.

Authors: Koca, T. Sengun, Y. Atak, E. et al.

Source: International Journal of Radiation Research. Apr2025, Vol. 23 Issue 2, p365-370. 6p.

Treatment effect estimation by comparing observed and predicted outcomes: conditions for valid inference and practical illustration.

Authors: Meijerink LM Leeuwenberg AM Choi J et al.

Source: Diagnostic and prognostic research [Diagn Progn Res] 2026 Jul 24; Vol. 10 (1). Date of Electronic Publication: 2026 Jul 24.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101718985 Publication Model: Electronic Cited Medium: Internet ISSN: 2397-7523 (Electronic) Linking ISSN: 23977523 NLM ISO Abbreviation: Diagn Progn Res Subsets: PubMed not MEDLINE

Survival and prognostic factors in adult medulloblastoma: the Salah Azaiz Institute experience.

Authors: Abidi, Rim Boussarsar, Amal Yahyaoui, Safia et al.

Source: British Journal of Neurosurgery. Apr2024, Vol. 38 Issue 2, p472-475. 4p.

'CROSS'-ing into the 'Real World': a retrospective cohort study of patients receiving trimodality and bimodality therapy for esophageal cancer.

Authors: Higgins LM Lester-Coll NH Ades S et al.

Source: Journal of gastrointestinal oncology [J Gastrointest Oncol] 2023 Apr 29; Vol. 14 (2), pp. 480-493. Date of Electronic Publication: 2023 Apr 24.

Publication Type: Journal Article

Journal Info: Publisher: AME Publishing Group Country of Publication: China NLM ID: 101557751 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2078-6891 (Print) Linking ISSN: 20786891 NLM ISO Abbreviation: J Gastrointest Oncol Subsets: PubMed not MEDLINE

Brain metastases in non-small-cell lung cancer treated with tyrosine kinase inhibitors.

Authors: Zarzeczna, Marta Rucińska, Monika

Source: Palliative Medicine in Practice. 2026, Vol. 20, p1-6. 6p.

Effects of EGFR-TKIs combined with intracranial radiotherapy in EGFR-mutant non-small cell lung cancer patients with brain metastases: a retrospective multi-institutional analysis.

Authors: He, Mingfeng Wu, Xue Li, Li et al.

Source: Radiation Oncology. 1/9/2025, Vol. 20 Issue 1, p1-12. 12p.

Cost-effectiveness analysis of additional local prostate radio therapy in metastatic prostate cancer from a medicare perspective.

Authors: Kramer, Kristina K. M. Schmidt-Hegemann, Nina-Sophie Westhofen, Thilo et al.

Source: Radiation Oncology. 11/21/2024, Vol. 19 Issue 1, p1-11. 11p.

Optimal timing of hypofractionated stereotactic radiotherapy for epidermal growth factor receptor‐mutated non‐small‐cell lung cancer patients with brain metastases.

Authors: Liang, Shimeng Liu, Xiaoqin Liu, Jia et al.

Source: Asia Pacific Journal of Clinical Oncology. Dec2023, Vol. 19 Issue 6, p731-738. 8p.

Markov models for clinical decision‐making in radiation oncology: A systematic review.

Authors: McCullum, Lucas B Karagoz, Aysenur Dede, Cem et al.

Source: Journal of Medical Imaging & Radiation Oncology. Aug2024, Vol. 68 Issue 5, p610-623. 14p.

Trends and costs of stereotactic body radiation therapy in metastatic non-small cell lung cancer.

Authors: Lester-Coll NH Skelly J Vacek PM et al.

Source: Journal of thoracic disease [J Thorac Dis] 2022 Jul; Vol. 14 (7), pp. 2579-2590.

Publication Type: Journal Article

Journal Info: Publisher: AME Publishing Company Country of Publication: China NLM ID: 101533916 Publication Model: Print Cited Medium: Print ISSN: 2072-1439 (Print) Linking ISSN: 20721439 NLM ISO Abbreviation: J Thorac Dis Subsets: PubMed not MEDLINE